Los Angeles Capital Management & Equity Research Inc. acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,782 shares of the medical instruments supplier’s stock, valued at approximately $764,000.

Several other large investors also recently bought and sold shares of the company. Alps Advisors Inc. increased its stake in shares of DENTSPLY SIRONA by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock worth $488,000 after purchasing an additional 20 shares in the last quarter. Wetherby Asset Management Inc. increased its stake in shares of DENTSPLY SIRONA by 0.6% in the 2nd quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock worth $324,000 after purchasing an additional 30 shares in the last quarter. HighTower Advisors LLC increased its stake in shares of DENTSPLY SIRONA by 0.6% in the 1st quarter. HighTower Advisors LLC now owns 6,823 shares of the medical instruments supplier’s stock worth $424,000 after purchasing an additional 39 shares in the last quarter. Atria Investments LLC increased its stake in shares of DENTSPLY SIRONA by 1.5% in the 2nd quarter. Atria Investments LLC now owns 4,541 shares of the medical instruments supplier’s stock worth $294,000 after purchasing an additional 68 shares in the last quarter. Finally, Advantus Capital Management Inc increased its stake in shares of DENTSPLY SIRONA by 0.4% in the 1st quarter. Advantus Capital Management Inc now owns 22,995 shares of the medical instruments supplier’s stock worth $1,436,000 after purchasing an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 93.87% of the company’s stock.

XRAY has been the subject of several analyst reports. BidaskClub lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, June 10th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a research note on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price objective for the company. Credit Suisse Group restated an “outperform” rating and issued a $75.00 price objective (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price objective for the company in a research note on Thursday, July 13th. Finally, Stifel Nicolaus restated a “buy” rating and issued a $66.00 price objective (down from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $65.73.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 57.81 on Friday. DENTSPLY SIRONA Inc. has a one year low of $52.54 and a one year high of $65.68. The company has a 50-day moving average of $56.98 and a 200 day moving average of $61.67. The company’s market cap is $13.27 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The company had revenue of $992.70 million during the quarter, compared to analysts’ expectations of $1 billion. During the same quarter in the previous year, the company earned $0.76 earnings per share. The firm’s revenue for the quarter was down 2.9% on a year-over-year basis. Analysts anticipate that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be issued a $0.0875 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.61%. DENTSPLY SIRONA’s payout ratio is -10.09%.

TRADEMARK VIOLATION WARNING: This piece was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.dailypolitical.com/2017/09/22/los-angeles-capital-management-equity-research-inc-invests-764000-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.